Immunization experts urge stronger action to close vaccination gaps in Africa
Experts, policymakers and global health partners have called for stronger, coordinated action to prevent backsliding on progress made against vaccine-preventable... Read more.
Imfinzi approved in the EU as first and only perioperative immunotherapy for muscle-invasive bladder cancer
Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the Imfinzi... Read more.
Philips Advances MRI Speed and Precision with FDA 510(k) Clearance of SmartSpeed Precise Dual AI Software
Continuing its momentum in AI-powered MR, Philips has received FDA 510(k) clearance for SmartSpeed Precise MR’s latest deep learning reconstruction software, marking... Read more.
Global Fund Commends Suriname’s Elimination of Malaria
Suriname has officially been certified malaria-free by the World Health Organization (WHO), becoming the first country in the Amazon region to eliminate the disease.... Read more.
Senegal Introduces Hexavalent Vaccine into its National Immunization Programme
Senegal officially launched the introduction of the hexavalent vaccine into its Expanded Program on Immunization (EPI). Following in Mauritania’s footsteps,... Read more.
WHO launches bold push to raise health taxes and save millions of lives
The “3 by 35” Initiative targets tobacco, alcohol, and sugary drinks to cut deaths and boost health and development funding The World Health Organization (WHO)... Read more.
Peng Xiao Appointed Chairman of the Board of Directors of Cleveland Clinic Abu Dhabi to advance AI-led healthcare
Cleveland Clinic Abu Dhabi has appointed Peng Xiao, Group CEO of G42 and member of the Artificial Intelligence and Advanced Technology Council (AIATC), as Chairman... Read more.
World Leaders Recommit to Immunisation Amid Global Funding Shortfall
At the Global Summit: Health and Prosperity through Immunisation in Brussels, world leaders pledged support for Gavi, the Vaccine Alliance, leading to a total of... Read more.
Amgen’s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study
Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6) met its primary endpoint of overall... Read more.
Dubai Hosts the 6th Edition of the Middle East, Africa and Russia Hematology Summit “MASH”
The Hematology Medical Conference, sponsored by AbbVie, the global research and development company in the field of biopharmaceuticals, kicked off for the sixth... Read more.
